# A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes

> **NCT02784275** · PHASE2 · COMPLETED · sponsor: **NovMetaPharma Co., Ltd.** · enrollment: 64 (actual)

## Conditions studied

- Diabetes Mellitus Type 2 in Obese

## Interventions

- **DRUG:** Cyclo-Z
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02784275
- **Lead sponsor:** NovMetaPharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-09
- **Primary completion:** 2017-05-03
- **Final completion:** 2017-05-17
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784275, "A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02784275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*